Bone Biologics Corp (BBLGW) Other Non-Current Liabilities (2022 - 2025)

Bone Biologics (BBLGW) has reported Other Non-Current Liabilities for 4 consecutive years, with $703.0 the latest figure, recorded in Q4 2025.

• In Q4 2025, Other Non-Current Liabilities fell 84.95% year-over-year to $703.0; the TTM figure through Dec 2025 stood at $703.0 (down 84.95% YoY), while the FY2025 annual figure was $703.0, down 84.95% from the prior year.
• Other Non-Current Liabilities fell to $703.0 in Q4 2025 per BBLGW's latest filing, from $1201.0 in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $1.7 million in Q1 2023 and bottomed at $703.0 in Q4 2025.
• Historically, Other Non-Current Liabilities has averaged $294236.8 across 4 years, with a median of $17629.0 in 2024.
• Annual changes were most pronounced in 2024 — Other Non-Current Liabilities tumbled 98.94% — and 2025, when it plunged 68.48%.
• Bone Biologics' Other Non-Current Liabilities stood at $1.7 million in 2022, then sank by 96.64% to $55751.0 in 2023, then sank by 91.62% to $4670.0 in 2024, then tumbled by 84.95% to $703.0 in 2025.
• Business Quant data shows BBLGW's Other Non-Current Liabilities at $703.0 in Q4 2025, $1201.0 in Q3 2025, and $2413.0 in Q2 2025.